Colorectal cancer immunotherapy-Recent progress and future directions

W Zhao, L Jin, P Chen, D Li, W Gao, G Dong - Cancer letters, 2022 - Elsevier
Compared with conventional chemotherapy and targeted therapy, immunotherapy has
changed the treatment prospects of various solid tumors and has recently become the main …

[HTML][HTML] Colorectal cancer vaccines: The current scenario and future prospects

W Jia, T Zhang, H Huang, H Feng, S Wang… - Frontiers in …, 2022 - frontiersin.org
Colorectal cancer (CRC) is one of the most common cancers worldwide. Current therapies
such as surgery, chemotherapy, and radiotherapy encounter obstacles in preventing …

Trial watch: Dendritic cell-based interventions for cancer therapy

L Galluzzi, L Senovilla, E Vacchelli, A Eggermont… - …, 2012 - Taylor & Francis
Dendritic cells (DCs) occupy a central position in the immune system, orchestrating a wide
repertoire of responses that span from the development of self-tolerance to the elicitation of …

Tuning Bacterial Morphology to Enhance Anticancer Vaccination

CX Li, Y Qi, Y Chen, Y Zhang, B Li, J Feng, XZ Zhang - ACS nano, 2023 - ACS Publications
Morphology tuning is a potent strategy to modulate physiological effects of synthetic
biomaterials, but it is rarely explored in microbe-based biochemicals due to the lack of …

Cellular vaccine approaches

DT Le, DM Pardoll, EM Jaffee - The Cancer Journal, 2010 - journals.lww.com
Therapeutic cancer vaccines aim to generate immunologic targeting of cancer cells through
the induction of effective cellular and antibody-mediated responses specific for antigens …

Autologous dendritic cells pulsed with allogeneic tumor cell lysate in mesothelioma: from mouse to human

JGJV Aerts, PL de Goeje, R Cornelissen… - Clinical Cancer …, 2018 - AACR
Purpose: Mesothelioma has been regarded as a nonimmunogenic tumor, which is also
shown by the low response rates to treatments targeting the PD-1/PD-L1 axis. Previously …

Immunotherapy for medulloblastoma: current perspectives

TF Kabir, CA Kunos, JL Villano… - ImmunoTargets and …, 2020 - Taylor & Francis
Background Immune-mediated therapies have transformed the treatment of metastatic
melanoma and renal, bladder, and both small and non-small cell lung carcinomas …

Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress

F Rastin, H Javid, MA Oryani, N Rezagholinejad… - International …, 2024 - Elsevier
There are increasing incidences and mortality rates for colorectal cancer in the world. It is
common for chemotherapy and radiation given to patients with colorectal cancer to cause …

Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells

R Aguilera, C Saffie, A Tittarelli, FE González… - Clinical Cancer …, 2011 - AACR
Purpose: This study characterizes, biologically and clinically, a novel type of dendritic cells
(DC) produced in the short term and called tumor antigen–presenting cells (TAPCells). In …

[HTML][HTML] Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced …

M Caballero-Baños, D Benitez-Ribas, J Tabera… - European Journal of …, 2016 - Elsevier
Background Autologous tumour lysate dendritic cell vaccine (ADC) has T-cell stimulatory
capacity and, therefore, potential antitumour activity. We designed a phase II randomised …